World Health Organization. Guidelines on Prevention and Control of Hospital Associated Infections. New Delhi, India; 2002.
Gottrup F, Melling A, Hollander DA. An overview of surgical site infections: aetiology, incidence and risk factors. EMWA J. 2005;5:11-15.
Klevens RM, Edwards JR, Richards CL, et al. Estimating healthcare-associated infections and deaths in U.S. hospitals, 2002. Pub Health Reports. 2007;122:160-166.
Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for prevention of surgical site infection, 1999 AM J Infect Control. 1999;27:97-134.
Whitehouse JD. The impact of surgical site infections following orthopedic surgery at a community hospital and a university hospital: adverse quality of life, excess length of stay, and extra cost. Infect Control Hosp Epidem. 2002;23:183-189.
Fry DE. The economic costs of surgical site infection. Surg Infect. 2002;3(suppl):S37-S43.
Bratzler DW, Houck PM for the Surgical Infection Prevention Guideline Writers Workshop. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Am J Surg. 2005:395-404.
Storch ML, Rothenburger SJ, Jacinto G. Experimental efficacy study of coated VICRYL plus antibacterial suture in guinea pigs challenged with Staphylococcus aureus. Surg Infect. 2004;5:281-288.
Rothenburger S, Spangler D, Bhende S, Burkley D. In vitro antimicrobial evaluation of coated VICRYL* Plus Antibacterial Suture (coated polyglactin 910 suture with triclosan) using zone of inhibition assays. Surg Infect. 2002;3:S79-S87.
Gilbert P, McBain AJ. Literature-based evaluation of the potential risks associated with impregnation of medical devices and implants with triclosan. Surg Infect. 2002;3:S55-S63.
Edmiston CE, Seabrook GR, Goheen MP, et al. Bacterial adherence to surgical sutures: can antibacterial-coated sutures reduce the risk of microbial contamination? J Am Coll Surg. 2006;203:481-489.
